AIMBLE
Aimble is an AI drug development company that offers drugs to treat intractable diseases.
AIMBLE
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2020-05-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.aimble.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
400 M KRW
Technology used in webpage:
Person Schema Gravatar Profiles Oracle Cloud
Similar Organizations
April Bio
April Bio is a drug development company that develops antibodies and long-acting biologics.
Autophagy Science
Autophagy Science is a drug development company specializing in the development of treatments for intractable diseases.
CELLnLIFE
CELLnLIFE develops stem cell therapy for the treatment of rare and intractable diseases.
ProAbTech
ProAbTech is a research and development company that develops conjugated biological drugs.
Investors List
TIPS Program
TIPS Program investment in Non Equity Assistance - Aimble
Schmidt
Schmidt investment in Seed Round - Aimble
New Paradigm Investment
New Paradigm Investment investment in Seed Round - Aimble
Official Site Inspections
http://www.aimble.com
- Host name: ec2-13-125-135-123.ap-northeast-2.compute.amazonaws.com
- IP address: 13.125.135.123
- Location: Incheon South Korea
- Latitude: 37.4562
- Longitude: 126.7288
- Timezone: Asia/Seoul
- Postal: 21539
More informations about "Aimble"
Aimble - Crunchbase Company Profile & Funding
Organization. Aimble . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Aimble is an AI drug development company that โฆSee details»
Aimble
AI๊ธฐ๋ฐ ์ ์ฝ ํ๋ณด๋ฌผ์ง ๋ฐ๊ตด ํ๋ซํผ CADD, Computer-Aided Drug Design AIMBLE Structure-Based Drug Design Platform is generated by integrating high technologies of docking, AI, quantum โฆSee details»
Aimble - Funding, Financials, Valuation & Investors - Crunchbase
Aimble is an AI drug development company that offers drugs to treat intractable diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much funding โฆSee details»
Aimble
AIM at a B etter L ife E xtension ๋ ๋์ ์๋ช ์ฐ์ฅ์ ๋ชฉํ๋ก. ์ฌ๋์ ๋๊ตฌ๋ ํ์ด๋์ ๋๊ณ ๋ณ๋ค์ด ์ฃฝ๋ ์ ํํ ์๋ช ์ฒด์ ๋๋ค. ์์๋ธ์ ์ฌ๋์ด ์๋ช ์ ์ฃผ๊ธฐ์ ๊ฑธ์ณ ๊ฑด๊ฐํ๊ณ ํ๋์ ์ธ ์ถ์ โฆSee details»
Aimble Company Profile 2024: Valuation, Funding & Investors
Aimble was founded in 2020. Who is the CEO of Aimble? Hyunjin Kim Ph.D is the CEO of Aimble. Where is Aimble headquartered? Aimble is headquartered in Seoul, South Korea. What is the โฆSee details»
Aimble - Company Profile - Tracxn
Oct 31, 2024 Aimble ranks 141st among 271 active competitors. 98 of its competitors are funded while 10 have exited. Overall, Aimble and its competitors have raised over $7.74B in funding โฆSee details»
Aimble - Products, Competitors, Financials, Employees, โฆ
Aimble's technology predicts drug efficacy by analyzing accumulated bio/medical data with its proprietary AI models. It was founded in 2020 and is based in Seoul, South Korea. โฆSee details»
Aimble - Crunchbase
Aimble is an AI drug development company that offers drugs to treat intractable diseases.See details»
Aimble | VentureRadar
Aimbleโs high-throughput docking solution is an automated computing tool to predict bound conformations and binding free energies for large libraries of chemicals to the target as well as โฆSee details»
Aimble
์ ·๋ณ์ข ๋ฐ์ด๋ฌ์ค ๋์ ์ ์ ๋ฐฑ์ ๋ฐ ํญ๋ ธํ ์น๋ฃ์ฉ ๋ฐฑ์ ๋ฑ ๊ฐ๋ฐ ๊ณํ์ฌ์ง: (์ผ์ชฝ๋ถํฐ) ๋ฐฑ์ค๋ค์ ๊น์ฑ์ฌ ๋ํ, ์์๋ธ ๊นํ์ง ๋ํ(์ ๊ณต=๋ฐฑ์ค๋ค์).์ด ๊ธฐ์ฌ๋ฅผ ๋ง์ด ์ฝ์ ์์ฌํต๊ณ๋ฅผ ์ํ โฆSee details»
Aimble - Company info. interviews, news - BiopharmaTrend
Developer of an automated drug screening platform designed to predict bound conformations and binding free energies for large libraries of chemicals โฆSee details»
AIMBLE Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AIMBLE Inc. of Uijeongbu, Gyeonggi. Get the latest business insights from Dun & Bradstreet.See details»
Aimble Stock Price, Funding, Valuation, Revenue & Financial โฆ
Jan 7, 2021 See Aimble funding rounds, investors, investments, exits and more. Evaluate their financials based on Aimble's post-money valuation and revenue. Aimble Stock Price, Funding, โฆSee details»
Aimble - VentureRadar
Similar Companies: Genesis Therapeutics USA Private Genesis Therapeutics is Unifying AI and Biotech. We're pairing proven drug developers with the industry's most advanced small โฆSee details»
Aimble - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Aimble is actively using 3 technologies for its website, according to BuiltWith. These include Amazon , Person Schema , and Gravatar Profiles . Website Tech Stack by BuiltWithSee details»
A Nimble organization makes experiments but pivots quickly
Feb 16, 2024 The report presents 3 imperatives for an organization to be โnimbleโ: Addressing Stakeholder Expectations by being customer-value driven; 2) Being a Data-Driven โฆSee details»
The five trademarks of agile organizations | McKinsey
Jan 22, 2018 When pressure is applied, the agile organization reacts by being more than just robust; performance actually improves as more pressure is exerted. 4 Research shows that โฆSee details»
Aimble
Aimble ... Aimble HomepageSee details»
Agile Organizations | McKinsey & Company
You know what an agile organization is, and why itโs important. But figuring out how to pull off an agile transformation... Article. How to mess up your agile transformation in seven easy โฆSee details»
A nimble organisation adapts quickly to an exponentially changing โฆ
Nov 25, 2021 Q. What is the core of your research? A. I started by studying teams and asking how we can understand what makes teams high-performing. What emerged was the idea of X โฆSee details»